Acarix AB
F:7AC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Acarix AB
F:7AC
|
SE |
|
Siemens AG
XETRA:SIE
|
DE |
|
L
|
Lam Research Corp
SWB:LAR
|
US |
|
Cellectis SA
LSE:0WA2
|
FR |
|
D
|
DigitalOcean Holdings Inc
XBER:0SU
|
US |
|
A
|
Apollo Medical Holdings Inc
F:3AM
|
US |
|
Verisign Inc
NASDAQ:VRSN
|
US |
|
L
|
Las Vegas Sands Corp
XBER:LCR
|
US |
|
Y
|
Yellow Cake PLC
XMUN:0LZ
|
JE |
|
Allegion PLC
NYSE:ALLE
|
IE |
|
Intellia Therapeutics Inc
NASDAQ:NTLA
|
US |
|
S
|
Sumitomo Chemical Co Ltd
TSE:4005
|
JP |
|
C
|
China Merchants Bank Co Ltd
XBER:M4B
|
CN |
|
D
|
Devon Energy Corp
BMV:DVN
|
US |
|
D
|
Darden Restaurants Inc
SWB:DDN
|
US |
|
R
|
Rio Tinto PLC
SWB:RIOA
|
UK |
|
A
|
ASML Holding NV
XMUN:ASME
|
NL |
|
W
|
Wynn Resorts Ltd
BMV:WYNN
|
US |
|
A
|
Avnet Inc
XMUN:VNI
|
US |
|
N
|
Novartis AG
XBER:NOT
|
CH |
|
C
|
Carnival Corp
F:CVC1
|
US |
|
K
|
Kennedy-Wilson Holdings Inc
F:13K
|
US |
Acarix AB
Acarix AB is a Swedish medical technology company that makes a heart disease screening system called CADScor. The system is used in clinics to help doctors quickly rule out coronary artery disease by analyzing heart sounds, rather than waiting for more expensive imaging or invasive tests. Its main customers are hospitals, cardiology clinics, and other healthcare providers that treat patients with chest pain or suspected heart disease. Acarix makes money by selling or placing its diagnostic devices, along with the disposable sensor patches and related service and support that go with each test. What makes Acarix different is that it sits at the front end of the heart-care workflow. Instead of treating disease directly, it helps physicians decide which patients are unlikely to have coronary artery disease and may not need further cardiac testing, which can save time and guide patients to the right next step in care.
Acarix AB is a Swedish medical technology company that makes a heart disease screening system called CADScor. The system is used in clinics to help doctors quickly rule out coronary artery disease by analyzing heart sounds, rather than waiting for more expensive imaging or invasive tests.
Its main customers are hospitals, cardiology clinics, and other healthcare providers that treat patients with chest pain or suspected heart disease. Acarix makes money by selling or placing its diagnostic devices, along with the disposable sensor patches and related service and support that go with each test.
What makes Acarix different is that it sits at the front end of the heart-care workflow. Instead of treating disease directly, it helps physicians decide which patients are unlikely to have coronary artery disease and may not need further cardiac testing, which can save time and guide patients to the right next step in care.
This earnings call has not been analyzed yet.
If you’d like us to analyze this earnings call, click the "Request Earnings Call Analysis" button below.
